Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.

[1]  A. van der Ende,et al.  Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis , 2014, BMJ Open.

[2]  J. Stoddard,et al.  A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program , 2013, Drugs.

[3]  S. Ladhani,et al.  Added value of PCR-testing for confirmation of invasive meningococcal disease in England. , 2013, The Journal of infection.

[4]  M. Snape,et al.  A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn? , 2013, Expert review of vaccines.

[5]  M. Goldacre,et al.  Maternal and perinatal factors associated with subsequent meningococcal, Haemophilus or enteroviral meningitis in children: database study , 2013, Epidemiology and Infection.

[6]  R. Viner,et al.  Long-Term Sequelae of Childhood Bacterial Meningitis , 2013, Current Infectious Disease Reports.

[7]  M. Goldacre,et al.  Increase in emergency admissions to hospital for children aged under 15 in England, 1999–2010: national database analysis , 2013, Archives of Disease in Childhood.

[8]  N. Andrews,et al.  Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales , 2013, Emerging infectious diseases.

[9]  Elizabeth Miller,et al.  Changes in Molecular Epidemiology of Streptococcus pneumoniae Causing Meningitis following Introduction of Pneumococcal Conjugate Vaccination in England and Wales , 2012, Journal of Clinical Microbiology.

[10]  N. Andrews,et al.  Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. , 2012, Vaccine.

[11]  S. Ladhani,et al.  Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. , 2012, Vaccine.

[12]  P. Ziprin,et al.  Systematic review of discharge coding accuracy. , 2012, Journal of public health.

[13]  N. Andrews,et al.  Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. , 2011, Vaccine.

[14]  P. Diggle,et al.  Meningococcal Disease in Children in Merseyside, England: A 31 Year Descriptive Study , 2011, PloS one.

[15]  N. Andrews,et al.  Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. , 2011, The Lancet. Infectious diseases.

[16]  S. Ladhani,et al.  The Impact of Haemophilus influenzae Serotype B Resurgence on the Epidemiology of Childhood Invasive Haemophilus influenzae Disease in England and Wales , 2011, The Pediatric infectious disease journal.

[17]  I. Rudan,et al.  Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.

[18]  N. Andrews,et al.  Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006. , 2010, The Journal of infection.

[19]  E. Miller,et al.  Meningococcal C conjugate vaccine: the experience in England and Wales. , 2009, Vaccine.

[20]  Carlos G. Grijalva,et al.  Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  D. Kelly,et al.  Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  R. Pebody,et al.  Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England. , 2007, The Journal of infection.

[23]  M. Heys,et al.  Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign , 2007, Archives of Disease in Childhood.

[24]  H. Peltola,et al.  Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data , 2004, BMJ : British Medical Journal.

[25]  Paul R Hunter,et al.  Geographic correlation between deprivation and risk of meningococcal disease: an ecological study , 2004, BMC public health.

[26]  J. McVernon,et al.  Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. , 2003, The Journal of infectious diseases.

[27]  X. Sáez-Llorens,et al.  Bacterial meningitis in children. , 2005, Pediatric clinics of North America.

[28]  F. Shann,et al.  Return of Haemophilus influenzae type b infections , 2003, The Lancet.

[29]  J. McVernon,et al.  Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis , 2003, The Lancet.

[30]  J. McVernon,et al.  The UK Hib vaccine experience , 2002, Archives of disease in childhood.

[31]  M. Ramsay,et al.  Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. , 2001, Vaccine.

[32]  K. Schoendorf,et al.  National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. , 1994, Pediatrics.

[33]  Jones Dm,et al.  Meningococcal infections in England and Wales: report of the Meningococcal Reference Laboratory for 1990. , 1991 .

[34]  P. Mäkelä,et al.  Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. , 1977, Pediatrics.

[35]  M. Goldacre,et al.  Completeness of statutory notification for acute bacterial meningitis. , 1976, British medical journal.

[36]  R. Chamberlain.  HOSPITAL IN‐PATIENT ENQUIRY , 1958 .

[37]  Samir S. Shah,et al.  Trends in invasive pneumococcal disease-associated hospitalizations. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  C. Whitney.  Eff ectiveness of pneumococcal conjugate vaccine , 2006 .

[39]  R. Heyderman,et al.  Capture-recapture analysis and pneumococcal meningitis estimates in England. , 2004, Emerging infectious diseases.

[40]  E. Kaczmarski,et al.  Meningococcal infections in England and Wales: report of the Meningococcal Reference Laboratory for 1990. , 1991, CDR.